Diagnostic significance of Drs. Wyatt & Chi's recent European Urology publication (video link)

Date Posted: 
2017-03-09

A study led by Drs. Kim Chi & Alex Wyatt demonstrated that metastatic castration-resistant prostate cancer patients with germline DNA repair defects respond poorly to androgen receptor-targeted therapy. However, biallelic gene loss was robustly detected in circulating tumor DNA, suggesting that this patient subset could be prioritized for therapies exploiting defective DNA repair using a liquid biopsy.  Click here for the publication, "Treatment Outcomes and Tumor Loss of Heterozygosity in Germline DNA Repair–deficient Prostate Cancer" in the journal European Urology (March 2 issue, link opens in new window).

Click here to see a Prostate Cancer Canada video (YouTube) of Dr. Wyatt discussing the diagnostic significance of the article.

 

A World Class Centre

The Vancouver Prostate Centre (VPC) has a track record of success that has earned it a reputation as one of the world’s most respected cancer facilities. It is a National Centre of Excellence and a designated Centre of Excellence for Commercialization and Research.

Events

PCC Plaid for Dad

Plaid for Dad: June 15, 2018

The VPC is proudly wearing plaid this Friday to raise funds for Prostate Cancer Canada. Click here to visit our team page and donate.

Raymond James Father's Day Walk Run 2018

Father's Day Walk Run: June 17, 2018

The Raymond James Father's Day Walk Run fundraiser for Prostate Cancer Foundation BC takes place Sunday June 17, 2018. Visit the event page for locations and registration. Click here to sponsor the Vancouver Prostate Centre team.

Employment

Work at the Vancouver Prostate Centre

Tuesday, May 29, 2018

Three VPC trainees receive 2018 VCHRI Rising Star Awards

2018 Rising Star Awardees
Wednesday, May 9, 2018

MSFHR Health Professional-Investigator award for Dr Black

Dr. Peter Black
DNA

Make A Difference

Help the Vancouver Prostate Centre fund research to find better treatments and a cure.